ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Keytruda improves PFS in classical Hodgkin lymphoma
March 06, 2020MSD has announced more Keytruda (pembrolizumab) results, this time for the treatment of adult patients with relapsed or refractory classical Hodgkin lymphoma (cHL). -
FDA expands approval of Adcetris for Stage III or IV classical Hodgkin lymphoma
March 27, 2018The FDA has approved Adcetris to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma in combination with chemotherapy…
Pharma Sources Insight January 2025
